Important news & announcements
Osorio brings experience as nurse and patient to role with NASH
Noemi Osorio knew she wanted to be a nurse after she spent nearly a month in the hospital as a young child. Nurses made her feel welcome and cared for while she recovered from surgery. Now she offers that same level of care as a registered nurse and NASH’s...
Journal of Healthcare Management article supports case for NASH’s Travel-for-Treatment model
A recent editorial in the Journal of Healthcare Management outlines the numerous opportunities and challenges related to what’s commonly referred to as “medical tourism.” NASH offers a unique alternative to medical tourism, Travel-for-Treatment, and its groundbreaking...
Roeder brings crucial experience as patient services nurse to NASH
Tawny Roeder worked for more than 11 years as a patient services nurse coordinator for Nebraska Medicine, the state’s top-ranked hospital and among the leading cancer treatment centers in the country. In that role, she witnessed how the high cost of medical care can...
Insights from our blog
Tackling Specialty Drug Affordability: Empowering Self-Insured Employers to Regain Control Over Specialty Pharmacy Spend
The specialty drug affordability issue Prescription drug use and spend has been steadily increasing in the U.S. and around the world. In fact, less than 5% of the U.S. population requires treatment with specialty drugs, yet they account for over 50% of net drug...
How to increase employee engagement in pharmacy benefits
Summary Learn how employers can increase employee engagement in NASH programs through incentive programs like non-cash compensation, contests, and polypharmacy bundling. These strategies not only boost participation but also improve healthcare literacy and...
NASH can help navigate Florida’s Drug Importation Program
We are in an era where healthcare costs often soar sky-high. Ensuring affordable medications for patients is more important than ever. Florida is taking a significant step in that direction with the recent FDA authorization of its innovative drug importation program....